Amprion
PrivateLast Round
Series B
Oct 9, 2024
Total Funding Raised
$16.66M
Company Overview
Amprion is a biotechnology company that develops diagnostic tests to detect misfolded proteins for the early diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amprion Comparables
Compare Amprion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CND Life Sciences | 87% | |
| Sunbird Bio | 81% | |
| C2N Diagnostics | 80% | |
Amprion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 9, 2024 | ||||
| Grant | Sep 12, 2024 | ||||
| Grant | May 10, 2022 | ||||
| Grant | Apr 15, 2021 | ||||
| Grant | Nov 15, 2020 |
Key People
Founding team and executive leadership
Amprion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Formation Venture Engineering | Series B |
| ALS Network | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| Alzheimer's Drug Discovery Foundation | Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 14, 2025
Monthly visitors increased 59% MoM.
- Jun 2, 2025
Monthly visitors grew 42% MoM, reaching 1.7K.
Amprion Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amprion's valuation, stock price, and market status.